About CUC Group
PT CUC HEALTHCARE INDONESIA (CHI) is the Indonesian subsidiary of CUC Inc., which was listed on the Tokyo Stock Exchange (TSE) Growth Market in 2023, with revenue of 47 billion yen in the fiscal year ending March 2025.
CUC Group addresses Japanese healthcare needs by vertically providing services from hospital care to home health and end-of-life care.
The domestic footprint includes support for more than 160 medical institutions, operations of more than 50 hospice
residences, 90 in-home nursing stations, and 25 medical residences (as of September 2025).
We launched our international operations in 2019. This includes management assistance for medical facilities in Southeast Asia, along with the supply of equipment in the dialysis and ophthalmology sectors. In the United States, we are developing a system to provide clinical services in related podiatry fields, such as varicose vein treatment. We also started initiatives regarding OBLs (Office-Based Laboratory) in the United States in 2025.
Our Services in Indonesia
Our Services
Leveraging our know-how from operating over 900 dialysis units in Japan, CUC offers seamless, comprehensive support—from facility launch and operation to KSO (Kerja Sama Operasi).
Ophthalmology Support Services
We offer KSO services for ophthalmic equipment and management support for eye clinics.
Other Services
CUC provides patient-first, safe medical services in Indonesia through partnerships with
top Japanese hospitals.
We operate a medical tourism services and provide support for dispatching caregiving
personnel to Japan, aiming to serve as a bridge between Indonesia and Japan.
